| American Academy of Dermatology-68th annual meeting. 5-9 March 2010, Miami Beach, FL, USA. | |
| | |
MedLine Citation:
|
PMID: 20432186 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The American Academy of Dermatology, held in Miami Beach, FL, USA, included topics covering new therapeutic and diagnostic developments in the field of dermatological diseases. This conference report highlights selected presentations on melanoma, including genetic risk factors, improvements in detection, molecular classification and targeting BRAF mutations, and on psoriasis, including the immunology of psoriasis, biological therapies and psoriasis as a systemic illness. |
| | |
Authors:
|
Talley Whang; Gary Goldenberg |
Related Documents
:
|
7009676 - The making of dermatologic surgeons. the first decade of the american society for derma... 1641236 - Binocular vision section. 21178906 - Management of cardiac electrical implantable devices in patients nearing the end of lif... 10603026 - The present and future state of pediatric neurosurgery in latin america. 12048576 - Streblidae (diptera) of phyllostomid bats from minas gerais, brazil. 12467346 - The painter and the cameraman: boundaries in clinical relationships. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: IDrugs : the investigational drugs journal Volume: 13 ISSN: 2040-3410 ISO Abbreviation: IDrugs Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-04-30 Completed Date: 2010-08-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883655 Medline TA: IDrugs Country: England |
Other Details:
|
Languages: eng Pagination: 311-3 Citation Subset: IM |
Affiliation:
|
Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029-6574, USA. talley.whang@mountsinai.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antineoplastic Agents / pharmacology, therapeutic use Drug Delivery Systems Humans Immunologic Factors / pharmacology, therapeutic use Melanoma / diagnosis, drug therapy*, genetics Mutation Proto-Oncogene Proteins B-raf / drug effects Psoriasis / drug therapy*, immunology Risk Factors Skin Neoplasms / diagnosis, drug therapy*, genetics |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents; 0/Immunologic Factors; EC 2.7.1.37/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: PHup2DATE 2010: Guideline-Compliant Diagnosis and Therapy of Pulmonary Hypertension.
Next Document: Superbugs and Superdrugs - SMi's 12th Annual Conference - Overcoming Resistance.